Hermesbio
9 employees on LinkedIn · 1 known investors
Hermes Biosciences develops a benchtop system for isolating extracellular vesicles and exosomes from bodily fluids and cell culture media for research and clinical applications in oncology, degenerative disease, and regenerative medicine.
Investors · 1
Frequently asked questions
- What does Hermesbio do?
- Hermes Biosciences develops a benchtop system for isolating extracellular vesicles and exosomes from bodily fluids and cell culture media for research and clinical applications in oncology, degenerative disease, and regenerative medicine.
- Who are Hermesbio's investors?
- Hermesbio's investors include Genoa Ventures.